Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-Week results of the RESIST-2 trial

  1. Cahn, P.
  2. Villacian, J.
  3. Lazzarin, A.
  4. Katlama, C.
  5. Grinsztejn, B.
  6. Arasteh, K.
  7. López, P.
  8. Clumeck, N.
  9. Gerstoft, J.
  10. Stavrianeas, N.
  11. Moreno, S.
  12. Antunes, F.
  13. Neubacher, D.
  14. Mayers, D.
Aldizkaria:
Clinical Infectious Diseases

ISSN: 1058-4838

Argitalpen urtea: 2006

Alea: 43

Zenbakia: 10

Orrialdeak: 1347-1356

Mota: Artikulua

DOI: 10.1086/508352 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus